Axsome Therapeutics, Inc. Liquidation Value

AXSM Other

Cash & Equivalents

$322.93M
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $322.93M
Total Obligations: -$526.95M
$-204.02M
Per share: $-4.01
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $322.93M
AR: $224.46M
Total Obligations: -$526.95M
$20.45M
Per share: $0.40
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $322.93M
AR: $224.46M
Inventory: $27.94M
Total Obligations: -$526.95M
$48.39M
Per share: $0.95
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-204.02M$-4.01
Liquid Liquidation Value$20.45M$0.40
Operating Liquidation Value$48.39M$0.95

Key Components (as of 2025-12-31)

Cash & Equivalents$322.93M
Accounts Receivable$224.46M
Inventory$27.94M
Current Liabilities$378.84M
Long-term Debt$117.75M
Op. Lease Liability$23.62M
Finance Lease$6.75M
Shares Outstanding50.9M

Explore all 208 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$322.93M$224.46M$27.94M$65.54M$378.84M$117.75M$23.62M$6.75M
2025-09-30$325.27M$196.51M$23.77M$54.23M$360.29M$117.64M$23.78M$7.18M
2025-06-30$303.02M$198.82M$18.44M$91.63M$342.10M$117.54M$23.96M$5.81M
2025-03-31$300.91M$161.40M$16.32M$85.66M$243.91M$181.38M$24.36M$5.50M
2024-12-31$315.35M$142.00M$15.73M$72.00M$230.10M$180.71M$7.88M$4.36M
2024-09-30$327.34M$124.10M$14.27M$64.25M$196.19M$180.00M$8.07M$4.23M
2024-06-30$315.66M$120.34M$15.22M$61.34M$186.57M$179.33M$8.25M$4.22M
2024-03-31$331.44M$101.43M$15.58M$53.79M$144.05M$178.69M$8.41M$2.33M

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-02-23 View
2025-09-30 10-Q 2025-11-03 View
2025-06-30 10-Q 2025-08-04 View
2025-03-31 10-Q 2025-05-05 View
2024-12-31 10-K 2025-02-18 View
2024-09-30 10-Q 2024-11-12 View
2024-06-30 10-Q 2024-08-05 View
2024-03-31 10-Q 2024-05-06 View

Community Notes

Loading notes...

Questions

Loading questions...